deltatrials
Completed OBSERVATIONAL NCT02777892

Pulmonic SAPIEN S3™ THV Registry (PulmonicS3)

Pulmonic SAPIEN S3™ THV Registry A Multi-center, Observational Registry With Retrospective Enrollment of Patients That Underwent Transcatheter Pulmonic Valve Implantation and a Retrospective or Prospective Follow-up

Sponsor: Institut für Pharmakologie und Präventive Medizin

Interventions Sapien S3
Updated 17 times since 2017 Last updated: Sep 12, 2023 Started: Mar 31, 2016 Primary completion: Mar 31, 2023 Completion: Jul 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Pulmonary Valve Malfunction and Right Ventricular Outflow Tract (RVOT) Dysfunction and is currently completed. Institut für Pharmakologie und Präventive Medizin leads this study, which shows 17 recorded versions since 2016 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Sep 2017 · 8 months · monthly snapshot~Sep 2017 – ~Apr 2018 · 7 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Mar 2019 · 5 months · monthly snapshot~Mar 2019 – ~Dec 2020 · 21 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Sep 2021 · 6 months · monthly snapshot~Sep 2021 – ~Jun 2022 · 9 months · monthly snapshot~Jun 2022 – ~Apr 2023 · 10 months · monthly snapshot~Apr 2023 – ~Jul 2023 · 3 months · monthly snapshot~Jul 2023 – ~Oct 2023 · 3 months · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

17 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Oct 2023 — Jul 2024 [monthly]

    Completed

    Status: Active Not RecruitingCompleted

  5. Jul 2023 — Oct 2023 [monthly]

    Active Not Recruiting

Show 12 earlier versions
  1. Apr 2023 — Jul 2023 [monthly]

    Active Not Recruiting

  2. Jun 2022 — Apr 2023 [monthly]

    Active Not Recruiting

  3. Sep 2021 — Jun 2022 [monthly]

    Active Not Recruiting

  4. Mar 2021 — Sep 2021 [monthly]

    Active Not Recruiting

  5. Jan 2021 — Mar 2021 [monthly]

    Active Not Recruiting

  6. Dec 2020 — Jan 2021 [monthly]

    Active Not Recruiting

  7. Mar 2019 — Dec 2020 [monthly]

    Active Not Recruiting

    Status: RecruitingActive Not Recruiting

  8. Oct 2018 — Mar 2019 [monthly]

    Recruiting

  9. Jun 2018 — Oct 2018 [monthly]

    Recruiting

  10. Apr 2018 — Jun 2018 [monthly]

    Recruiting

    Phase: NANone

  11. Sep 2017 — Apr 2018 [monthly]

    Recruiting NA

  12. Jan 2017 — Sep 2017 [monthly]

    Recruiting NA

    First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institut für Pharmakologie und Präventive Medizin
Data source: Institut für Pharmakologie und Präventive Medizin

For direct contact, visit the study record on ClinicalTrials.gov .